肺癌手術市場規模、佔有率、成長分析，按設備類型、最終用戶、地區分類 - 產業預測 2024-2031

2022年全球肺癌手術市場規模為56億美元，從2023年的59億美元成長到2031年的81億美元，在預測期內（2024-2031年）年複合成長率為4.1%。

全球市場細分 該市場是醫療保健行業中一個充滿活力的部分，受與肺癌相關的高盛行率和死亡率的推動。外科技術和技術的最新進展，特別是電視輔助胸腔手術 (VATS) 和機器人輔助手術等微創手術，改善了患者的治療效果，包括減輕疼痛和縮短恢復時間。主要市場促進因素包括肺癌發生率上升、早期檢測意識增強以及人口老化。儘管取得了這些進展，但挑戰仍然存在，例如治療成本上升以及發展中地區的治療機會差異。醫療設備製造商、醫院和研究機構之間正在進行的研究工作和合作旨在克服這些障礙，並提高全球肺癌手術的可用性和有效性。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及前景

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特分析及影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 生態系繪圖
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 案例研究
• 技術評估
• 監管環境
• 疾病流行病學
• 專利分析

肺癌手術市場規模：依設備類型及年複合成長率（2024-2031）

• 市場概況
• 手術器械
  • 粉體手術器械
  • 手用儀器
  • 訂書機
  • 鉗子
  • 牽開器
  • 肋骨剪刀
  • 刀具
  • 夾鉗
  • 剪刀
  • 套管針
  • 電梯
  • 其他
• 監控及視覺化系統
  • 相機和影片支持
  • 具有光學視野的內視鏡套管針
• 內視鏡手術設備

肺癌手術市場規模：按類型和年複合成長率（2024-2031）

• 市場概況
• 開胸手術
  • 切除術
  • 袖狀切除術
  • 部分切除術
  • 肺切除術
• 微創手術

肺癌手術市場規模：依最終用戶和年複合成長率（2024-2031）

• 市場概況
• 醫院
• 門診手術中心

肺癌手術市場規模及年複合成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
• 產品系列分析
• 按細分市場分類的佔有率分析
• 收益與前一年同期比較（2021-2023）

主要企業簡介

• Ethicon Llc.（Johnson & Johnson Group）
• Medtronic Plc.
• Olympus Corporation
• Intuitive Surgical Inc.
• Siemens Healthineers
• Teleflex Incorporated
• Accuray Incorporated
• Angiodynamics Inc.
• Key Surgical Llc.
• KLS Martin Group
• Ackermann Instrumente Gmbh
• Karl Storz Gmbh
• Scanlan International, Inc.
• Trokamed Gmbh
• Surgical Holdings
• Fusionkraft Surgical Instruments
• Richard Wolf Gmbh
• Sontec Instruments Inc.
• Wexler Surgical Inc.
• Phoenix Surgical Instruments Ltd.（Steris Ims）

結論和建議

Global Lung Cancer Surgery Market size was valued at USD 5.6 billion in 2022 and is poised to grow from USD 5.9 billion in 2023 to USD 8.1 billion by 2031, growing at a CAGR of 4.1% during the forecast period (2024-2031).

The global Lung Cancer Surgery market is a dynamic segment of the healthcare industry, driven by the high prevalence and mortality associated with lung cancer. Recent advancements in surgical techniques and technologies, particularly minimally invasive procedures like video-assisted thoracic surgery (VATS) and robotic-assisted surgery, have led to improved patient outcomes, including reduced pain and shorter recovery times. Key market growth drivers include the rising incidence of lung cancer, heightened awareness for early detection, and an aging population. Despite these advancements, challenges such as high treatment costs and access disparities in developing regions persist. Ongoing research efforts and collaborations among medical device manufacturers, hospitals, and research institutions aim to overcome these obstacles, enhancing the availability and effectiveness of lung cancer surgeries globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lung Cancer Surgery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Lung Cancer Surgery Market Segmental Analysis

Global Lung Cancer Surgery Market is segmented by Device Type, Type, End-User and Region. Based on Device Type, the market is segmented into Surgical instruments, Monitoring & Visualizing Systems, Endosurgical Equipment. Based on Type, the market is segmented into Thoracotomy, Minimally Invasive Surgeries. Based on End-User, the market is segmented into Hospitals, Ambulatory Surgery Centres. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Lung Cancer Surgery Market

The global lung cancer surgery market is significantly driven by the rising prevalence of lung cancer, recognized as the leading cause of cancer-related deaths among both men and women worldwide. This alarming trend is largely attributed to the tobacco epidemic, particularly in developing countries, where the rates of lung cancer incidence and mortality are sharply increasing. The profound impact of lung cancer extends beyond physical health, profoundly affecting patients and their families, and it is increasingly regarded as a critical global health challenge. Lung cancer itself is characterized by the uncontrolled growth of lung cell tissues, necessitating effective surgical interventions for treatment.

Restraints in the Global Lung Cancer Surgery Market

The global lung cancer surgery market faces several restraints that may hinder its growth. One significant factor is the high cost associated with the surgical procedures, which can deter patients and healthcare providers from pursuing necessary treatments. Additionally, technical limitations present in certain countries further restrict the availability of advanced surgical options. Prolonged lead times required for obtaining international qualifications can complicate market entry and expansion efforts. Furthermore, the fierce competition within the medical technology sector adds another layer of challenge, potentially stifling innovation and limiting the overall progress of the lung cancer surgery market.

Market Trends of the Global Lung Cancer Surgery Market

The Global Lung Cancer Surgery market is experiencing a significant trend towards increased research and development, aimed at enhancing treatment modalities and surgical techniques. Ongoing clinical trials are pivotal in evaluating the effectiveness and safety of innovative approaches, such as targeted therapies, immunotherapies, and minimally invasive procedures. This trend is driven by the rising incidence of lung cancer globally, leading to a surge in demand for advanced surgical interventions. As pharmaceutical and medical device companies invest heavily in R&D, the market anticipates a wave of breakthroughs, ultimately improving patient outcomes and transforming standard practices in lung cancer treatment.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Assessment
• Regulatory Landscape
• Disease Epidemiology
• Patent Analysis

Global Lung Cancer Surgery Market Size by Device Type & CAGR (2024-2031)

• Market Overview
• Surgical instruments
  • Powdered Surgical Instruments
  • Hand Instruments
  • Staplers
  • Forceps
  • Retractors
  • Rib Shears
  • Cutters
  • Clamps
  • Scissors
  • Trocars
  • Elevators
  • Others
• Monitoring & Visualizing Systems
  • Cameras and Video Support
  • Endoscopic Trocars with Optical Views
• Endosurgical Equipment

Global Lung Cancer Surgery Market Size by Type & CAGR (2024-2031)

• Market Overview
• Thoracotomy
  • Lobectomy
  • Sleeve Resection
  • Segmentectomy
  • Pneumonectomy
• Minimally Invasive Surgeries

Global Lung Cancer Surgery Market Size by End-User & CAGR (2024-2031)

• Market Overview
• Hospitals
• Ambulatory Surgery Centres

Global Lung Cancer Surgery Market Size & CAGR (2024-2031)

• North America (Device Type, Type, End-User)
  • US
  • Canada
• Europe (Device Type, Type, End-User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Device Type, Type, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Device Type, Type, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Device Type, Type, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Ethicon Llc. (Johnson & Johnson Group)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intuitive Surgical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accuray Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Angiodynamics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Key Surgical Llc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KLS Martin Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ackermann Instrumente Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Karl Storz Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Scanlan International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trokamed Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Surgical Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fusionkraft Surgical Instruments
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Richard Wolf Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sontec Instruments Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wexler Surgical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phoenix Surgical Instruments Ltd. (Steris Ims)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation